Estimating cardiac exposure from breast cancer radiotherapy in clinical practice.

Estimating cardiac exposure from breast cancer radiotherapy in clinical practice.

PURPOSE: To assess the value of maximum heart distance (MHD) in predicting the dose and biologically effective dose (BED) to the heart and the left anterior descending (LAD) coronary artery for left-tangential breast or chest wall irradiation. METHODS AND MATERIALS: A total of 50 consecutive breast...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Taylor, C, McGale, P, Povall, J, Thomas, E, Kumar, S, Dodwell, D, Darby, S
Format:	Journal article
Język:	English
Wydane:	2009

Podobne zapisy

Cardiac irradiation in breast radiotherapy
od: Taylor, C, i wsp.
Wydane: (2007)

Cardiac exposures in breast cancer radiotherapy: 1950s-1990s.
od: Taylor, C, i wsp.
Wydane: (2007)

Cardiac dose from tangential breast cancer radiotherapy in the year 2006.
od: Taylor, C, i wsp.
Wydane: (2008)

Cardiac risks of breast-cancer radiotherapy: a contemporary view.
od: Taylor, C, i wsp.
Wydane: (2006)

Heart and coronary artery doses from breast radiotherapy
od: Taylor, C, i wsp.
Wydane: (2006)

Erratum: Cardiac dose from tangential breast cancer radiotherapy in the year 2006 (International Journal of Radiation Oncology Biology Physics (2008) 72 (501-507))
od: Taylor, C, i wsp.
Wydane: (2013)

Eligibility for partial breast radiotherapy in England
od: Taylor, CW, i wsp.
Wydane: (2019)

Cardiac doses from Swedish breast cancer radiotherapy since the 1950s.
od: Taylor, C, i wsp.
Wydane: (2009)

Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001
od: Taylor, C, i wsp.
Wydane: (2011)

Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001.
od: Taylor, C, i wsp.
Wydane: (2011)

Effects of radiotherapy and surgery for early breast cancer - Authors' reply
od: Darby, S, i wsp.
Wydane: (2006)

Long-term mortality from heart disease after radiotherapy for early breast cancer
od: Darby, S, i wsp.
Wydane: (2007)

Mortality from cardiovascular disease after radiotherapy for breast cancer in 298,885 women registered in the SEER cancer registries
od: Darby, S, i wsp.
Wydane: (2004)

Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer
od: Henson, K, i wsp.
Wydane: (2013)

Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer.
od: Henson, K, i wsp.
Wydane: (2013)

Effect of radiotherapy after mastectomy and axillary dissection on recurrence and breast cancer mortality: Meta-analysis of individual patient data from randomised trials
od: McGale, P, i wsp.
Wydane: (2014)

Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries
od: Henson, KE, i wsp.
Wydane: (2020)

Cardiac disease and second lung cancer after radiotherapy for breast cancer.
od: Correa, C, i wsp.
Wydane: (2009)

Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.
od: Darby, S, i wsp.
Wydane: (2005)

Cardiac structure injury after radiotherapy for breast cancer: cross-sectional study with individual patient data
od: Taylor, C, i wsp.
Wydane: (2018)

A cardiac contouring atlas for radiotherapy
od: Duane, F, i wsp.
Wydane: (2017)

Breast cancer radiotherapy: exposure of the heart and lungs
od: Duane, F
Wydane: (2018)

Dosimetry based on radiotherapy treatment planning
od: Taylor, C, i wsp.
Wydane: (2007)

A cardiac contouring atlas for radiotherapy.
od: Duane, F, i wsp.
Wydane: (2017)

Ki67 and breast cancer mortality in women with invasive breast cancer
od: Probert, J, i wsp.
Wydane: (2023)

Ischemic heart disease and breast cancer radiotherapy: the way forward.
od: Taylor, C, i wsp.
Wydane: (2014)

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015
od: Aznar, M, i wsp.
Wydane: (2018)

Exposure of the oesophagus in breast cancer radiotherapy: a systematic review of oesophagus doses published 2010-2020
od: Duane, FK, i wsp.
Wydane: (2021)

Uncertainties in estimating heart doses from 2D-tangential breast cancer radiotherapy
od: Lorenzen, E, i wsp.
Wydane: (2016)

Risk of ischemic heart disease in women after radiotherapy for breast cancer.
od: Darby, S, i wsp.
Wydane: (2013)

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
od: Kerr, AJ, i wsp.
Wydane: (2022)

Estimating the risks of breast cancer radiotherapy: Evidence from modern radiation doses to the lungs and heart and from previous randomised trials
od: Taylor, C, i wsp.
Wydane: (2017)

Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005
od: Rehammar, J, i wsp.
Wydane: (2017)

Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden.
od: McGale, P, i wsp.
Wydane: (2011)

Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden
od: McGale, P, i wsp.
Wydane: (2011)

The 2006 worldwide overview of the effects of local treatments for early breast cancer on long-term outcome
od: McGale, P, i wsp.
Wydane: (2006)

The 2006 worldwide overview of the effects of local treatments for early breast cancer on long-term outcome
od: Darby, S, i wsp.
Wydane: (2006)

Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women.
od: Darby, S, i wsp.
Wydane: (2003)

What is the risk of cardiac morbidity with adjuvant radiotherapy for breast cancer?
od: Vallis, K
Wydane: (2006)

Overview of the Randomised Trials of Radiotherapy in Early Breast Cancer.
od: Darby, S, i wsp.
Wydane: (2009)